These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
806 related articles for article (PubMed ID: 31498483)
1. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway. Liu S; Zhang Y; Huang C; Lin S J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
3. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity. Zhang HR; Chen JM; Zeng ZY; Que WZ J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505 [TBL] [Abstract][Full Text] [Related]
5. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
6. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway. He W; Fu Y; Zheng Y; Wang X; Liu B; Zeng J BMC Cancer; 2021 Feb; 21(1):125. PubMed ID: 33549034 [TBL] [Abstract][Full Text] [Related]
7. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635 [TBL] [Abstract][Full Text] [Related]
8. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway. Zhang YM; Wu QM; Chang LY; Liu JC Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698 [TBL] [Abstract][Full Text] [Related]
9. MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14. Zhang H; Zhang X; Zhang J Biochem Biophys Res Commun; 2018 Nov; 506(1):272-277. PubMed ID: 30348524 [TBL] [Abstract][Full Text] [Related]
10. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Ma X; Ren H; Zhang Y; Wang B; Ma H Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241 [TBL] [Abstract][Full Text] [Related]
11. miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation. Jin Y; Ni S J Cell Biochem; 2020 Jan; 121(1):698-712. PubMed ID: 31436348 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway. Han S; Chen Y; Gao Y; Sun B; Kong Y Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
14. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Gu Y; Fei Z; Zhu R Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198 [TBL] [Abstract][Full Text] [Related]
15. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
17. 2,3,5,4'-Tetrahydroxy-stilbene-2- Yang L; Xing W; Xiao WZ; Tang L; Wang L; Liu MJ; Dai B Pharm Biol; 2020 Dec; 58(1):806-814. PubMed ID: 32881597 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245 [TBL] [Abstract][Full Text] [Related]
20. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway. Ling Z; Fang ZG; Wu JY; Liu JJ Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]